Tags |
|
|
Links |
|
|
Top Articles - Jim Cramer, Pickpocket
I love Jim Cramer.
Here is a man who knows his business and how to use the tools of his trade. He made his fortune (and my guess he has b
Here is a man who knows his business and how to use the tools of his trade. He made his fortune (and my guess he has b
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
een smart enough to keep it) using those tools.
He is not alone as all the good hedge fund managers know (or should know) them and are us
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ng them today. Don’t blame him because he is better than the others.
If anyone is a stay-at-home day trader they do not have the ability
If anyone is a stay-at-home day trader they do not have the ability
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
to do any of the things that the powerful money managers can. They are at the mercy of market manipulation. The day trader walks up to the
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
plate with 2 ? strikes on him and the ball is already half way there. It is strike three before he has had a chance to swing.
In a recent
In a recent
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
interview on YouTube Jim let loose with a few of the inside tricks he used when he was a fund manager. It is a hard ball game. All the pro
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
s use technical analysis such as volume, chart formations, MACDs, stochastics, etc. because fundamentals mean nothing. Those are standard.
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
Manipulation comes in false-feeding the media with information that can short term move the market in any direction either up or down. Wh
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
n a fund has millions of dollars to buy or sell options it can influence a stock’s price is one of many tricks.
Fund managers like Jim, a
Fund managers like Jim, a
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
nd there are hundreds of them, are moving stock and option prices every day. They are literally picking each others pockets. The most skil
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ful win. The little guy at home with his less-than-$100,000 account hasn’t a chance. He is what is known as a mushroom.
Mushroom? Yes, so
Mushroom? Yes, so
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ething grown in the dark and fed horse manure.
It is unfortunate that most of the regulators at the SEC, CFTC and NFA also fall into this
It is unfortunate that most of the regulators at the SEC, CFTC and NFA also fall into this
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
category because they have never been traders. I attest to this because I was an exchange member and floor trader.
For years I have been
For years I have been
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
criticizing the regulators for not protecting the little guy. I don’t care about hedge fund investors. They have enough money and should k
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ow better. They can afford to buy good advice, but greed usually blinds them. There are good hedge funds and there are good mutual funds,
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
but unfortunately there are more poor ones in both categories than good ones.
The regulators should be doing more to help the “little gu
The regulators should be doing more to help the “little gu
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
”. About 80% of the 401Ks have less than $50,000 deposited in standard mutual funds. As a bench mark they compare themselves with the S&P5
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
0 and most can’t beat this average. During a bear market the regulators will not allow the funds to hold large cash or bond positions to k
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
eep from losing customers’ money. Fund managers are paid on how much money is in the fund and not on how much they make for the investor.
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
errible.
Jim proves by his statements that it is foolish to be a day trader. The long term facts prove it is foolish to be Buy and Holder
Jim proves by his statements that it is foolish to be a day trader. The long term facts prove it is foolish to be Buy and Holder
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.toparticles.org.ua/article/102005/toparticles-Jim-Cramer-Pickpocket.html">Jim Cramer, Pickpocket</a>
BB link (for phorums):
[url=http://www.toparticles.org.ua/article/102005/toparticles-Jim-Cramer-Pickpocket.html]Jim Cramer, Pickpocket[/url]
Related Articles:
Ocean Affiliates - Riding the Crest of a New Wave in Online Marketing
Bookmark it:
|